Skyrizi 360 MG/2.4 ML on-body 2.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26F98F4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,467
Award facts
- Contract value 100% obligated
- $12,467.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,467 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 30, 2026, for the supply of SKYRIZI 360 mg/2.4 ml on-body applicator units. This non-competitive delivery order, with a completion date of February 23, 2026, represents a task order issued against AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999 through December 2031. The pharmaceutical supply will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, supporting the Defense Health Agency and broader military healthcare requirements.
This delivery order exemplifies the routine execution of DLA's pharmaceutical supply chain operations, where AmerisourceBergen leverages its comprehensive IDC to fulfill specialized medical product needs across the military health system. SKYRIZI, a biologic medication for dermatological conditions, demonstrates the breadth of therapeutic domains covered under the prime contract vehicle. As a non-set-aside award, this order was competitively solicited and reflects AmerisourceBergen's established capability to meet federal procurement standards for controlled pharmaceutical distribution to military treatment facilities and veterans' healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F98F4?
SPE2DR26F98F4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F98F4 worth?
The government has obligated $12,467 on SPE2DR26F98F4.
Is contract SPE2DR26F98F4 an order under another contract?
Yes. SPE2DR26F98F4 is a delivery order under SPE2DR25D3505, an indefinite delivery contract.
Was contract SPE2DR26F98F4 competed?
The extent of competition for SPE2DR26F98F4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award